Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mary Schillinger"'
Autor:
Martin Gignac, Timothy E. Wilens, Tiffany Parcell, Mary Schillinger, MaryKate Martelon, Joseph Biederman, Markus J. P. Kruesi, Diana Westerberg
Publikováno v:
The Journal of Clinical Psychiatry. 70:259-265
BACKGROUND Recent work has highlighted important relationships among conduct disorder (CD), substance use disorders (SUD), and bipolar disorder in youth. However, because bipolar disorder and CD are frequently comorbid in the young, the impact of CD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d94151e3a9f9d626049d71661ec170cb
https://doi.org/10.4088/jcp.08m04438
https://doi.org/10.4088/jcp.08m04438
Autor:
Rachel Shelley-Abrahamson, Aaron L. Baggish, Paul Hammerness, Mary Schillinger, Randall M. Zusman, Craig B. H. Surman, Timothy E. Wilens, David M. Systrom
Publikováno v:
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. 14(4)
Due to concerns about the safety of stimulants for ADHD, novel assessments of the cardiopulmonary impact of these agents are needed.An open design of lisdexamfetamine (LDX) in 15 adults with DSM-IV ADHD. Following a psychiatric evaluation and medical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeecb568bfc83781a922cdabe513f016
https://pubmed.ncbi.nlm.nih.gov/22559155
https://pubmed.ncbi.nlm.nih.gov/22559155
Autor:
Mary Schillinger, Kerry Brodziak, Timothy E. Wilens, Linsey M. Utzinger, Robert Doyle, Paul Hammerness, MaryKate Martelon, Joseph Biederman, Anna M. Georgiopoulos
The aim of this study was to evaluate the tolerability of adding OROS methylphenidate (MPH) to children who are partial responders to atomoxetine (ATMX) in the treatment of attention-deficit/hyperactivity disorder (ADHD).This was a two-phase, 7-week,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99d20aba0c33165316310254a3dad35c
https://europepmc.org/articles/PMC2861956/
https://europepmc.org/articles/PMC2861956/
Autor:
Timothy E. Wilens, MaryKate Martelon, Linsey M. Utzinger, Anna Georgiopoulous, Mary Schillinger, Kerry Brodziak, Paul Hammerness, Robert Doyle
This study evaluated the effectiveness of adding OROS methylphenidate (MPH) to children who are partial responders to atomoxetine (ATMX) in the treatment of attention-deficit/hyperactivity disorder (ADHD).This is a two-phase, 7-week, open study in ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b378812213fad6784745ed4596616797
https://europepmc.org/articles/PMC2861954/
https://europepmc.org/articles/PMC2861954/
Autor:
Stephen V. Faraone, Timothy E. Wilens, Joel J. Adamson, Diana Westerberg, Mary Schillinger, Michael C. Monuteaux, Joseph Biederman
Publikováno v:
Archives of Pediatrics & Adolescent Medicine. 162:916
Objective To examine the effects of early stimulant treatment on subsequent risk for cigarette smoking and substance use disorders (SUDs) in adolescents with attention-deficit/hyperactivity disorder (ADHD). Design Case-controlled, prospective, 5-year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2649e7102309937d3a36ddd6eec23860
https://doi.org/10.1001/archpedi.162.10.916
https://doi.org/10.1001/archpedi.162.10.916
Autor:
Timothy E. Wilens, Paul Hammerness, Linsey Utzinger, Mary Schillinger, Anna Georgiopoulous, Robert L. Doyle, MaryKate Martelon, Kerry Brodziak, Wilens, Timothy E, Hammerness, Paul, Utzinger, Linsey, Schillinger, Mary, Georgiopoulous, Anna, Doyle, Robert L, Martelon, Marykate, Brodziak, Kerry
Publikováno v:
Journal of Child & Adolescent Psychopharmacology; Oct2009, Vol. 19 Issue 5, p485-492, 8p
Autor:
Paul Hammerness, Anna Georgiopoulos, Robert L. Doyle, Linsey Utzinger, Mary Schillinger, MaryKate Martelon, Kerry Brodziak, Joseph Biederman, Timothy E. Wilens
Publikováno v:
Journal of Child & Adolescent Psychopharmacology; Oct2009, Vol. 19 Issue 5, p493-499, 7p